Why Jim Cramer Is Staying Away from Biotechs

Jim Cramer on his CNBC Mad Money program was bullish on biotechs all summer. This was after a surplus of biotech IPOs flooded the market in the spring, and the sector bottomed. Biotechs rebounded with a vengeance More...

8 Jim Cramer ‘Buys’ In the Fed Fallout

Actually, the Fed “fallout” wasn’t the crisis many expected. For years, the prophets of doom on Wall Street were terrified of that fateful day the Fed would cease its bond buying. They More...

Pharmaceutical industry giant Perrigo wins the $8.6 billion battle for Elan of Ireland

– There’s a lot happening in the pharmaceutical industry these days and one of the biggest deals so far this year will see US based Perrigo swallow up the Eire based Elan. Perrigo are the only non-Israeli More...